ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 32 filers reported holding ONCOLYTICS BIOTECH INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $156 | -15.2% | 129,856 | +15.3% | 0.00% | – |
| Q4 2022 | $184 | -99.4% | 112,600 | +357.7% | 0.00% | – |
| Q3 2022 | $30,000 | +114.3% | 24,600 | +75.7% | 0.00% | – |
| Q2 2022 | $14,000 | -65.0% | 14,000 | -45.1% | 0.00% | – |
| Q1 2022 | $40,000 | -87.8% | 25,500 | -89.2% | 0.00% | – |
| Q4 2021 | $327,000 | -25.5% | 235,478 | +12.2% | 0.00% | -100.0% |
| Q3 2021 | $439,000 | +585.9% | 209,900 | +812.6% | 0.00% | – |
| Q2 2021 | $64,000 | -84.6% | 23,000 | -86.8% | 0.00% | – |
| Q4 2020 | $415,000 | +1876.2% | 174,220 | +1284.3% | 0.00% | – |
| Q3 2020 | $21,000 | -63.8% | 12,585 | -70.0% | 0.00% | – |
| Q1 2020 | $58,000 | +163.6% | 41,999 | +11.3% | 0.00% | – |
| Q3 2019 | $22,000 | -63.9% | 37,751 | +138.9% | 0.00% | – |
| Q3 2018 | $61,000 | – | 15,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 5,302,036 | $11,558,438 | 2.33% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 201,453 | $449,240 | 0.06% |
| BRAVE ASSET MANAGEMENT INC | 25,000 | $54,927 | 0.02% |
| Ausdal Financial Partners, Inc. | 20,000 | $43,600 | 0.01% |
| HEADINVEST, LLC | 11,534 | $24,106 | 0.01% |
| Cedar Mountain Advisors, LLC | 5,651 | $12,319 | 0.00% |
| Long Focus Capital Management, LLC | 40,000 | $87,200 | 0.00% |
| Banque Cantonale Vaudoise | 11,900 | $26 | 0.00% |
| OSAIC HOLDINGS, INC. | 9,712 | $21,173 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 33,485 | $72,997 | 0.00% |